FDA Peptide Review
Peptide News Update — 8/27/2026 FDA Considering Reclassifying 14 Restricted Peptides During its high-stakes meeting on July 23–24, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) narrowly voted to recommend adding six of the seven reviewed peptides to the Section 503A Bulk Drug Substances List. This narrow vote directly opposed the recommendation of the FDA’s […]